TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $761,000 | -12.8% | 55,840 | +4.7% | 0.01% | -20.0% |
| Q3 2021 | $873,000 | -0.8% | 53,311 | +2.0% | 0.01% | -9.1% |
| Q2 2021 | $880,000 | -4.6% | 52,262 | +4.0% | 0.01% | -8.3% |
| Q1 2021 | $922,000 | -4.7% | 50,233 | -5.5% | 0.01% | -7.7% |
| Q4 2020 | $967,000 | -9.3% | 53,156 | -9.0% | 0.01% | -23.5% |
| Q3 2020 | $1,066,000 | -5.2% | 58,403 | -5.9% | 0.02% | -5.6% |
| Q2 2020 | $1,124,000 | +8.0% | 62,082 | -6.7% | 0.02% | -5.3% |
| Q1 2020 | $1,041,000 | -46.8% | 66,575 | -32.9% | 0.02% | -38.7% |
| Q4 2019 | $1,958,000 | +8.8% | 99,290 | -5.0% | 0.03% | +3.3% |
| Q3 2019 | $1,800,000 | -8.3% | 104,498 | -5.8% | 0.03% | -6.2% |
| Q2 2019 | $1,963,000 | -19.1% | 110,908 | -6.9% | 0.03% | -23.8% |
| Q1 2019 | $2,426,000 | – | 119,093 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |